Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00595
|
|||||
| Drug Name |
Chlorpheniramine
|
|||||
| Synonyms |
1-(p-Chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine; 1-(p-Chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; 2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine; 3-(4-chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine; 3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; 3-(p-Chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine; 4-Chloropheniramine; Aller-Chlor; Allergican; Allergisan; Antagonate; CHLORPHENIRAMINE (SEE ALSO: CHLORPHENIRAMINE MALEATE (CAS113-92-8)); Chlo-amine; Chlor-Pro; Chlor-Trimeton (TN); Chlor-Trimeton Repetabs; Chlor-Tripolon (TN); Chlor-trimeton; Chloropheniramine; Chlorophenylpyridamin; Chlorophenylpyridamine; Chloropiril; Chloroprophenpyridamine; Chlorphenamine; Chlorphenamine (INN); Chlorphenamine [INN]; Chlorphenaminum; Chlorphenaminum [INN-Latin]; Chlorpheniraminum; Chlorprophenpyridamine; Clofeniramina; Clofeniramina (TN); Clorfenamina; Clorfenamina [INN-Spanish]; Clorfeniramina; Clorfeniramina [Italian]; Cloropiril; Comakin (TN); Gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine; Gamma-(4-Chlorophenyl)-gamma-(2-pyridyl)propyldimethylamine; Gen-Allerate; Haynon; Hayon; Histadur; ISOCLOR; Kloromin; Novo-Pheniram; Pediacare Allergy Formula; Phenetron; PiriIton; Piriton; Piriton (TN); Polaronil; Telachlor; Teldrin; [3H]Chlorpheniramine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Allergic rhinitis [ICD11: CA08.0] | Approved | [1] | |||
| Urticaria [ICD11: EB00-EB0Y] | Approved | [1] | ||||
| Therapeutic Class |
Antiallergic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H19ClN2
|
|||||
| Canonical SMILES |
CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
|
|||||
| InChI |
InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m1/s1
|
|||||
| InChIKey |
SOYKEARSMXGVTM-OAHLLOKOSA-N
|
|||||
| CAS Number |
CAS 132-22-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 274.79 | Topological Polar Surface Area | 16.1 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
3.4
|
|||||
| PubChem CID | ||||||
| PubChem SID |
109896795
, 11110931
, 11110932
, 11112256
, 11363014
, 11365576
, 11368138
, 11371329
, 11373943
, 11376300
, 11484028
, 11487972
, 11490161
, 11492097
, 11493954
, 135650086
, 135774423
, 137002507
, 15442268
, 160666558
, 174007153
, 175269603
, 179039539
, 226396260
, 33774101
, 47719847
, 48018097
, 50064683
, 50100400
, 50225325
, 57304992
, 85789162
, 9299815
|
|||||
| ChEBI ID |
ChEBI:52010
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP1 | Transporter Info | Multidrug resistance-associated protein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Chlorpheniramine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Carrier mediated transport of chlorpheniramine and chlorcyclizine across bovine olfactory mucosa: implications on nose-to-brain transport. J Pharm Sci. 2005 Mar;94(3):613-24. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.